| Literature DB >> 34523147 |
Jarrod J Sandow1,2, Iris Kl Tan1,2, Alan S Huang1,2, Shashank Masaldan1,2, Jonathan P Bernardini1,2, Ahmad Z Wardak1, Richard W Birkinshaw1,2, Robert L Ninnis1,2, Ziyan Liu1,2, Destiny Dalseno1,2, Daisy Lio1, Giuseppi Infusini1,2, Peter E Czabotar1,2, Andrew I Webb1,2, Grant Dewson1,2.
Abstract
BAK and BAX, the effectors of intrinsic apoptosis, each undergo major reconfiguration to an activated conformer that self-associates to damage mitochondria and cause cell death. However, the dynamic structural mechanisms of this reconfiguration in the presence of a membrane have yet to be fully elucidated. To explore the metamorphosis of membrane-bound BAK, we employed hydrogen-deuterium exchange mass spectrometry (HDX-MS). The HDX-MS profile of BAK on liposomes comprising mitochondrial lipids was consistent with known solution structures of inactive BAK. Following activation, HDX-MS resolved major reconfigurations in BAK. Mutagenesis guided by our HDX-MS profiling revealed that the BCL-2 homology (BH) 4 domain maintains the inactive conformation of BAK, and disrupting this domain is sufficient for constitutive BAK activation. Moreover, the entire N-terminal region preceding the BAK oligomerisation domains became disordered post-activation and remained disordered in the activated oligomer. Removal of the disordered N-terminus did not impair, but rather slightly potentiated, BAK-mediated membrane permeabilisation of liposomes and mitochondria. Together, our HDX-MS analyses reveal new insights into the dynamic nature of BAK activation on a membrane, which may provide new opportunities for therapeutic targeting.Entities:
Keywords: BAK; BCL-2; apoptosis; hydrogen-deuterium exchange mass spectrometry; membrane
Mesh:
Substances:
Year: 2021 PMID: 34523147 PMCID: PMC8521275 DOI: 10.15252/embj.2020107237
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 14.012